Filing Details

Accession Number:
0001487371-21-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-08 18:01:41
Reporting Period:
2021-01-06
Accepted Time:
2021-01-08 18:01:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1487371 Genmark Diagnostics Inc. GNMK Surgical & Medical Instruments & Apparatus (3841) 272053069
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1775627 Tyler Jensen 5964 La Place Court
San Diego CA 92008
Svp, Engineering And Tech Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-06 16,823 $16.00 190,985 No 4 S Direct
Common Stock Acquisiton 2021-01-07 10,000 $9.96 200,985 No 4 M Direct
Common Stock Acquisiton 2021-01-07 7,000 $12.30 207,985 No 4 M Direct
Common Stock Acquisiton 2021-01-07 14,500 $13.17 222,485 No 4 M Direct
Common Stock Disposition 2021-01-07 32,477 $16.99 190,008 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-01-07 10,000 $9.96 10,000 $9.96
Common Stock Stock Option (Right to Buy) Disposition 2021-01-07 7,000 $12.30 7,000 $12.30
Common Stock Stock Option (Right to Buy) Disposition 2021-01-07 14,500 $13.17 14,500 $13.17
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-08-05 2023-08-05 No 4 M Direct
0 2018-03-06 2024-03-06 No 4 M Direct
0 2019-02-19 2025-02-19 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 7/20/2020.
  2. The price reported is the weighted average price per share. Shares were purchased in multiple transactions at prices ranging from $16.54 to $17.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price.